![Jim Tananbaum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jim Tananbaum active positions
Companies | Position | Start | End |
---|---|---|---|
Seranova Bio LLC
![]() Seranova Bio LLC BiotechnologyHealth Technology Seranova Bio LLC, founded in 2020, is a company based in New Haven, CT that is focused on establishing a new paradigm for therapeutic target discovery. The company's Rapid Extracellular Antigen Profiling (REAP) platform combines high-quality, comprehensive protein sampling with next-generation DNA sequencing to profile patients' autoantibodies with higher throughput and fidelity than existing technologies. Seranova Bio's technological breakthrough reveals, in much greater depth, the underlying humoral response to disease and provides critical insights to drug developers. The company aims to collaborate with pharmaceutical partners to discover novel therapeutic targets and develop new treatments for autoimmune disease, neurodegeneration, and cancer. | Director/Board Member | - | - |
Career history of Jim Tananbaum
Statistics
International
United States | 2 |
Operational
Director/Board Member | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Seranova Bio LLC
![]() Seranova Bio LLC BiotechnologyHealth Technology Seranova Bio LLC, founded in 2020, is a company based in New Haven, CT that is focused on establishing a new paradigm for therapeutic target discovery. The company's Rapid Extracellular Antigen Profiling (REAP) platform combines high-quality, comprehensive protein sampling with next-generation DNA sequencing to profile patients' autoantibodies with higher throughput and fidelity than existing technologies. Seranova Bio's technological breakthrough reveals, in much greater depth, the underlying humoral response to disease and provides critical insights to drug developers. The company aims to collaborate with pharmaceutical partners to discover novel therapeutic targets and develop new treatments for autoimmune disease, neurodegeneration, and cancer. | Health Technology |
- Stock Market
- Insiders
- Jim Tananbaum
- Experience